News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Celgene Revises Expansion Plan In Summit
October 26, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NJ.com -- SUMMIT – Given today’s economic climate, Celgene has scaled back its expansion plans.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
MORE ON THIS TOPIC
Mergers & acquisitions
UCB captures Candid in $2.2B autoimmune deal as pharma’s M&A train chugs along
May 4, 2026
·
2 min read
·
Tristan Manalac
Obesity
Obesity ends oncology’s long reign as top contributor to biopharma pipeline value
May 4, 2026
·
2 min read
·
Nick Paul Taylor
Manufacturing
Novartis unveils North Carolina API plant as final piece of $23B US expansion
May 1, 2026
·
2 min read
·
Nick Paul Taylor
Earnings
Moderna beats revenue expectations with $389M, but litigation dogs earnings
May 1, 2026
·
3 min read
·
Annalee Armstrong
